findmyKOL

Malissa Wood, MD

Enriched profile

Vice President and Chief Physician Executive, Lee Health Heart Institute · Lee Health Heart Institute

ORCIDNPI
Region🇺🇸 Fort Myers, FL · Southeast · United StatesSpecialtyCardiovascular DiseaseFocusCoronary Artery Disease / ACS
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNone verifiedPayments2021–2025NIH fundingNone on fileWhy? →

Malissa Wood is Vice President and Chief Physician Executive, Lee Health Heart Institute at Lee Health Heart Institute. OpenAlex indexes 188 publications with 8,664 citations (h-index 42); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Malissa J. Wood, MD, is Vice President and Chief Physician Executive, Lee Health Heart Institute. The public record shows 188 publications with 8,664 citations (h-index 42), centered on Coronary Artery Disease / ACS. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 13 companies.

  • Most recent indexed publication: 2024 · European heart journal. Case reports
  • Top research focus: Coronary Artery Disease / ACS
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 13 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Coronary Artery Dissection, Spontaneous1 trialCoronary Artery Disease / ACS1 trialMicrovascular Angina1 trial

Research focus

OpenAlex concept fingerprint
Coronary Artery Disease / ACS

Drugs & molecules

across trials, industry payments and publications
Rinvoqgeneric · UpadacitinibClinical trialsIndustry payments27PublicationsRezdiffrageneric · ResmetiromClinical trialsIndustry payments20PublicationsSkyrizigeneric · RisankizumabClinical trialsIndustry payments11Publications

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trialsIndustry payments67Heartflow, Inc.Clinical trialsIndustry payments61Pfizer Inc.Clinical trialsIndustry payments27

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
188publications

Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.

8,664citations

Total citations across indexed works.

42h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
13companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Public positions

sourced statements on record
  • Chair

    American College of Cardiology Board of Governors and Secretary, ACC Board of Trustees

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acc.org
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acc.org
1 more sourced public position behind the reveal.Reveal →

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    100%
    Statin67.5%
    Atorvastatin Calcium59%Simvastatin41%
    Part D<11 patients
    Beta blocker32.5%
    Metoprolol Succinate100%
    Part D11 patients
Where care is delivered (Part B), 202368.7% facility · 31.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    health.usf.edu/medicine/internalmedicine/cardiology/faculty/crousillatd

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usf.edu
  • X / Twitter

    X/Twitter: @drmalissawood

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com
  • LinkedIn

    LinkedIn: linkedin.com/in/malissa-wood-1607b010 (lists role at Women As One)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record
1 more award behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
1 more affiliation behind the reveal.Reveal →

Media & interviews

press, podcasts and appearances
4 more media items behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.